Latica, Gastro Health’s partner for data analytics, has collaborated with the American Gastroenterological Association (AGA) to support the IBD Living Guidelines Real-World Evidence Study. This initiative is powered by Latica’s proprietary data platform and robust clinical datasets from its GI Network comprised of Gastro Health and Allied Digestive Health. 

"This collaboration is an exciting opportunity to translate real-world evidence into actionable insights that directly enhance patient care,” said Dr. Eugenio Hernandez, Chief Medical Officer at Gastro Health. “By combining our extensive clinical expertise with Latica’s advanced AI, we can better understand how guidelines perform in everyday practice, identify opportunities for improvement, and ultimately deliver more personalized and effective care for our patients."

Unlike static clinical guidelines, these living guidelines evolve alongside advances in therapy and practice, supporting physicians with up-to-date decision-making tools

“By bringing together our physicians’ deep clinical expertise with Latica’s cutting-edge AI, we can see how guidelines play out in daily practice, uncover areas for refinement, and deliver care that is more personalized, precise, and effective for the patients we serve,” said Alan Oliver, Chief Executive Officer.

Learn more directly from the American Gastroenterological Association’s press release.

Tags Inflammatory Bowel Disease (IBD)